Riskpilot← Back to searchSign inGet full accessABL BIOTEC A/S
A/SActiveCVR 50811018Gemmavej 5Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 19741 employees
Revenue 2025
DKK -130K
-9% vs 2024
EBITDA margin
100.0%
+52% vs 2024
Equity ratio
99.7%
Financial strength
Net profit 2025
DKK -117K
-103% vs 2024
| Revenue | DKK -130K | -9% |
| EBITDA | DKK -130K | +52% |
| Net profit | DKK -117K | -103% |
| Total assets | DKK 28M | -8% |
| Equity | DKK 27,9M | -8% |
| Employees | 1 | — |
Legal name
ABL BIOTEC A/S
CVR number
50811018
Legal form
Aktieselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
12. december 1974
Share capital
DKK 1.000.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren, af bestyrelsesformanden eller af den samlede bestyrelse.
Company purpose
Selskabets formål er formueadministration.
Address
Gemmavej 5
Phone
+4523438929
Email
asgerbl@outlook.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -51 | -97 | -100 | -122 | -118 | -125 | -109 | -114 | -116 | -130 | -156 | -133 | -143 | -130 |
| Staff expenses | -124 | -121 | -121 | -121 | -121 | -121 | -120 | -180 | -120 | -120 | -120 | -126 | -128 | -0 |
| EBITDA | -174 | -217 | -222 | -244 | -239 | -246 | -229 | -294 | -236 | -250 | -277 | -259 | -271 | -130 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -174 | -217 | -222 | -244 | -239 | -246 | -229 | -294 | -236 | -250 | -277 | -259 | -271 | -130 |
| Net financials | 3.742 | 3.453 | 4.519 | 3.161 | 1.260 | 1.708 | -2.277 | 4.559 | 3.362 | 5.048 | -3.404 | 4.940 | 5.024 | -6 |
| Profit before tax | 3.568 | 3.235 | 4.298 | 2.918 | 1.021 | 1.461 | -2.507 | 4.264 | 3.126 | 4.798 | -3.681 | 4.681 | 4.753 | -136 |
| Tax | -118 | 511 | 523 | 687 | 225 | 322 | -551 | 956 | 671 | 1.067 | -805 | 1.029 | 1.048 | -19 |
| Net profit | 3.686 | 2.725 | 3.774 | 2.230 | 796 | 1.139 | -1.956 | 3.308 | 2.455 | 3.731 | -2.875 | 3.652 | 3.704 | -117 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 21.551 | 22.590 | 23.885 | 24.969 | 24.700 | 24.865 | 21.726 | 25.178 | 27.479 | 30.705 | 26.387 | 29.093 | 30.533 | 27.973 |
| Equity | 21.513 | 22.438 | 23.712 | 24.843 | 24.539 | 24.578 | 21.521 | 24.722 | 26.577 | 29.808 | 26.333 | 28.897 | 30.201 | 27.885 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 37 | 152 | 173 | 127 | 162 | 287 | 205 | 456 | 902 | 897 | 54 | 196 | 332 | 88 |
| Total debt | 37 | 152 | 173 | 127 | 162 | 287 | 205 | 456 | 902 | 897 | 54 | 196 | 332 | 88 |
EBITDA margin
-12994900.0%
This company
15.8%
Market median
-82246303% vs market
20122025
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20122025
Return on equity
-0.4%
This company
18.4%
Market median
-102% vs market
20122025
Net profit margin
-11672300.0%
This company
8.1%
Market median
-144102569% vs market
20122025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20122025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BV Management | Management | 1974 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1974 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 1974 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2024 | |
| Individual | 50.0% | 50.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ABL BIOTEC A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bent Varnich Pedersen | Management | 0 companies |
| Anna Kristine Pedersen | Board of Directors | 0 companies |
| Gitte Larsen | Board of Directors | 0 companies |
| Rikke Dahl Andersson | Board of Directors | 0 companies |
| Karen Margrethe Pedersen | Board of Directors | 0 companies |